Stocks and Investing Stocks and Investing
Thu, March 15, 2018
[ 12:00 AM ] - WOPRAI
Barry Jonas Maintained (AGS) at Strong Buy and Held Target at $24 on, Mar 15th, 2018
[ 12:00 AM ] - WOPRAI
Brandon Nispel Upgraded (AKAM) to Hold on, Mar 15th, 2018
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (C) at Buy with Increased Target to $93 on, Mar 15th, 2018
Wed, March 14, 2018
[ 12:00 AM ] - WOPRAI
Scott Krasik Maintained (CAL) at Strong Buy with Increased Target to $38 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Kutgun Maral Initiated (AMCX) at Hold and Held Target at $57 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Jeremy Tonet Maintained (AM) at Buy with Decreased Target to $23 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Michael Gambardella Upgraded (CENX) to Buy on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Michael Gambardella Maintained (CENX) at Buy with Increased Target to $29 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
David Katz Initiated (WYNN) at Hold and Held Target at $200 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Carlo Santarelli Maintained (WYNN) at Strong Buy with Decreased Target to $215 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Anupam Rama Maintained (SRPT) at Buy with Increased Target to $95 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Danyal Hussain Maintained (WEX) at Hold with Increased Target to $166 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Jeremy Tonet Maintained (WES) at Buy with Increased Target to $59 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (SNDX) at Buy with Decreased Target to $24 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Michael Kim Maintained (VRNS) at Buy with Increased Target to $23 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Ken Worthington Maintained (BLK) at Buy with Decreased Target to $640 on, Mar 14th, 2018
[ 12:00 AM ] - WOPRAI
Rob Oliver Initiated (TYL) at Buy and Held Target at $240 on, Mar 14th, 2018
Tue, March 13, 2018
[ 12:00 AM ] - WOPRAI
Mike McCormack Initiated (T) at Strong Buy and Held Target at $42 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
David Nierengarten Maintained (SYRS) at Buy with Increased Target to $130 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Phil Gresh Maintained (VLO) at Hold with Increased Target to $105 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Joseph Schwartz Maintained (SRPT) at Buy with Increased Target to $92 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (SRPT) at Buy with Increased Target to $100 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Gordon Johnson Downgraded (X) to Strong Sell on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Geoffrey Porges Maintained (WVE) at Buy with Decreased Target to $62 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Nithin Pejaver Downgraded (CHGG) to Hold on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (ALNY) at Buy with Increased Target to $154 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
John Guinee Downgraded (BDN) to Hold on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Jonathan Lanterman Maintained (ZG) at Buy with Increased Target to $55 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Jonathan Lanterman Maintained (Z) at Buy with Increased Target to $55 on, Mar 13th, 2018
[ 12:00 AM ] - WOPRAI
Seamus Fernandez Maintained (ACRS) at Buy with Decreased Target to $54 on, Mar 13th, 2018

Seamus Fernandez Maintained (ACRS) at Buy with Decreased Target to $54 on, Mar 13th, 2018


Published on 2024-10-26 03:46:08 - WOPRAI, Seamus Fernandez
  Print publication without navigation


Seamus Fernandez of Leerink Swann, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Buy with Decreased Target from $56 to $54 on, Mar 13th, 2018.

Seamus, nor any peers, have made any analyst calls on ACRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources